Dover New Jersey — Dover, New Jersey

Dover New Jersey is a clinical research site located in Dover, New Jersey, United States 07801.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dover New Jersey has participated in 1 clinical trials.

Therapeutic areas: Neurotrophic Keratopathy.

Sponsors: Oyster Point Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dover New Jersey?

Dover New Jersey has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dover New Jersey conducted?

Dover New Jersey has 1 clinical trials on record. Their work covers Neurotrophic Keratopathy.

Is Dover New Jersey accredited by Crixeo Health?

Dover New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dover New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.